Brown Advisory’s VanEck Biotech ETF BBH Stock Holding History

Brown Advisory’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-2,030	Closed	-$258K	–	996
2015 Q4	$258K	Buy	2,030 +80	+4%	+$9.8K	﹤0.01%	832
2015 Q3	$223K	Buy	+1,950	New	+$258K	﹤0.01%	860

Other funds holding BBH

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LFM

Lumina Fund Management New York $164M AUM 27.72% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $14.2B AUM 20.68% 1-Year Est. Return

Brown Advisory's BBH Position: Q1 2016 in Review

Brown Advisory sold out of VanEck Biotech ETF (BBH) in Q1 2016, closing a stake of 2,030 shares — an estimated $258K sold.

Brown Advisory first reported a position in BBH in Q3 2015 and held it in 2 quarters. The position peaked at $258K in Q4 2015. 71 funds tracked by Wall St. Rank hold BBH as of Q1 2016.

Brown Advisory reported no remaining VanEck Biotech ETF position as of Q1 2016 after selling out during the quarter.
Brown Advisory sold 2,030 VanEck Biotech ETF shares in Q1 2016, an estimated $258K.
Brown Advisory first reported a position in VanEck Biotech ETF in Q3 2015 and held it in 2 quarters.
Brown Advisory's VanEck Biotech ETF position peaked at $258K in Q4 2015.
71 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2016.

Based on Brown Advisory's 13F filing for Q1 2016, filed 13 May 2016.